OmanDocSign in

Curriculum · Hematology

Acute myeloid leukaemia: prognosis and cytogenetic risk

What it is

Prognosis in acute myeloid leukemia is read first from the achievement of first remission. It is achieved in 70-80% if 60 yr old or less, and in 50% if over 60. Median survival is 12-24 months.

Causes and risk

Prognosis is most related to cytogenetics and/or molecular abnormalities, and these sort into three groups:

NPM1 appears in two of the three groups, so it is not read alone: mutated NPM1 by itself is favorable, while mutated NPM1 with FLT3-ITD is intermediate.